Figure 6 — Identification of a circadian-based prognostic signature predicting cancer-associated fibroblasts infiltration and immunotherapy response in bladder cancer

Research Paper|Volume 16, Issue 17|pp. 12312–12334

Identification of a circadian-based prognostic signature predicting cancer-associated fibroblasts infiltration and immunotherapy response in bladder cancer

Back to articleFigure 6(6 of 11)

100%

Figure 6.Immune-related association of the risk model. The difference of high- and low-risk groups in tumor immune landscape evaluated by (A) CIBERSORT, (B) EPIC, (C) MCP-Counter, (D) QUANTISEQ, (E) TIMER and (F) XCELL. (G) Differences in the immune checkpoint-related genes expression between high- and low-risk groups. * p < 0.05, ** p < 0.01, *** p < 0.001.